Declan Murphy

declan.murphy@kcl.ac.uk

+44 (0) 207 848 0984

Biography

I am the Mortimer D. Sackler Professor of Translational Neurodevelopment, and Director of the Sackler Institute of Translational Neurodevelopment, Institute of Psychiatry Psychology and Neuroscience (IOPPN), King’s College London.  I am also Head of Department of Forensic and Neurodevelopmental Sciences (IOP), and Director of the Behavioural and Developmental Psychiatry Clinical Academic Group, King’s Health Partners, King’s College London. In the latter role my team comprises 600 people who see many thousands of patients a year, and they deliver both Local and National services for people with autism and ADHD, various genetically determined neurodevelopmental disorders (e.g. SHANK3 and 22Q abnormalities), and those with abnormal social behavior (e.g. offenders).

My undergraduate training in Medicine was at University College (London) and my postgraduate training in psychiatry at the Maudsley Hospital and IoPPN (London).  Afterwards, my research training was first at the IOPPN and then at NIH (Bethesda).  I returned from NIH to the UK in order to establish a ‘translational’ research program in neurodevelopment.

 

MD, National Institutes for Health (NIH), Bethesda, USA
MRCPsych (Member of the Royal College of Psychiatrists)
MBBS, University College London (UCL), UK

My overarching mission is to translate research from ‘bench to bedside’ and develop new diagnostic approaches and treatments.  The research work undertaken in my laboratory currently links to stem cells and animal models through to neuropsychological studies and neuroimaging, and clinical trials (including behavioural interventions) and Health Services research.

In autism, I lead the European Union Innovative Medicines Initiative in autism (EU-AIMS).  This is a novel collaboration between organizations representing affected individuals and their families (Autism Speaks), academia (14 academic centers) and Industry - who for the first time in the world have come together to develop the infrastructure underpinning the discovery of new treatments for autism.

...

Developmental disorders

Enabling quicker diagnosis and improved treatment of individuals with autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) and other cognitive and social developmental disorders.
...

Take part in our research

We conduct a large number of clinical trials which test new treatments or approaches to see whether they are effective. Find out more about how you can participate and what it involves.
News and Events